Jake Remaly is a newspaper reporter and blog editor with a penchant for uncovering the truth. With a focus on medical and healthcare topics, Jake's articles for Medscape delve into the latest research and developments in the field, providing valuable insights and information for healthcare professionals and the general public alike.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
International
Jake Remaly's articles predominantly focus on scientific and healthcare topics, often citing data. He would likely be interested in pitches from experts who can provide insights into the latest medical research findings or new developments in healthcare practices. If you have access to compelling data or are an expert in any of the specific medical fields covered such as pediatrics, pain management, menopause, osteoporosis, sleep disorders or vaccinations among others, Jake may find your input valuable for his articles.
Jake does not appear to have a specific geographic focus but rather covers a wide range of health-related topics with a strong emphasis on evidence-based information and scientific advancements.
This information evolves through artificial intelligence and human feedback. Improve this profile .
Benralizumab is now approved by the U.S. Food and Drug Administration (FDA) for the treatment of asthma in children over age 6.
The maintenance treatment for severe asthma with an eosinophilic phenotype originally was approved for patients aged 12 years and older.
A mix of microbes may help explain why some people develop dry eye disease, new research showed.
A chatbot had more instances of incorrect reasoning than doctors did but scored higher overall.
TOPLINE: A study comparing the clinical reasoning of an artificial intelligence (AI) model with that of physicians found the AI outperformed residents and attending physicians in simulated cases.
The US Food and Drug Administration has approved pivmecillinam (Pivya) tablets to treat uncomplicated urinary tract infections in women.
The US Food and Drug Administration (FDA) has approved a new treatment for uncomplicated urinary tract infections
Topical cefiderocol "could be a new weapon in the ophthalmologist's arsenal" to combat a strain of bacteria found last year in bottles of artificial tears, researchers report at ARVO 2024.
TOPLINE: Most children hospitalized with community-acquired pneumonia can reach clinical stability within 24 hours.
Dilated fundus exams have been the gold standard for detecting retinal tears in patients with acute posterior vitreous detachment (aPVD), but
(833) 317-6278 
